Background and activities
Gunnar Bovim works with policy matters related to education and research for NTNU’s top management.
- 2013–2019 Rector, NTNU (resigned 21 August 2019)
- 2009–2013 Chief Executive Officer, Central Norway Regional Health Authority
- 2006–2009 Chief Executive Officer, St. Olavs Hospital
- 2005–2006 Vice Chief Executive, St. Olavs Hospital
- 1999–2005 Dean, Faculty of Medicine, NTNU
- 1996–1998 Vice Dean, Faculty of Medicine, NTNU
- 1998–1999 Head of the Norwegian Neurological Association
- 1998 Chief physician and Professor of neurology, Faculty of Medicine, NTNU
- 1993 Dr.med. in neurology, University of Trondheim (now NTNU)
- 1985 Cand.med., University of Bergen
Boad and committee appointments and awards
Bovim has served on national and international committees and advisory boards on topics such as education, research, medicine and the health sector, including:
- Head of the board Innovation Norway 2018–2020
- Member and head of the board of directors for the Research Council of Norway’s Division for Health and Society
- Chairman of the Oslo University Hospital HF
- Board member, Central Norway Regional Health Authority
- Board member of the Bergen Research Foundation
- Board member of the Trondheim Symphony Orchestra
- Recipient of the Norwegian Migraine Society’s 1993 research prize
Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database
- (2011) Headache and migraine during pregnancy and puerperium: the MIGRA-study. The Journal of Headache and Pain. vol. 12 (4).
- (2010) The EEG response to photic stimulation is not increased in alcohol-related seizures. Clinical Neurophysiology. vol. 121 (11).
- (2010) Quantitative EEG in Patients With Alcohol-Related Seizures. Alcoholism: Clinical and Experimental Research. vol. 34 (10).
- (2009) Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia. vol. 29 (3).
- (2008) Cerebrospinal fluid cytokine levels in migraine, tension-type headache, and cervicogenic headache. Cephalalgia. vol. 29.
- (2008) Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. BMC Neurology. vol. 26 (8).
- (2007) Migraine aura or transient ischemic attacks? A five-year follow-up case-control study of women with transient central nervous system disorders in pregnancy. BMC Medicine. vol. 17 (5).
- (2006) Sickness absence is related to headache frequency. The HUNT Study. The Journal of Headache and Pain. vol. 7.
- (2006) Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. The Journal of Headache and Pain. vol. 7.
- (2006) Sick leave is related to frequencies of migraine and non-migrainous headache - The HUNT study. Cephalalgia. vol. 26.
- (2006) Involvement of the renin-angiotensin system in migraine. Journal of Hypertension. vol. 24 (1).
- (2005) Headache after whiplash is likely to represent stress-induced primary headache. Cephalalgia. vol. 25.
- (2005) Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurologica Scandinavica. vol. 111.
- (2005) Do high TSH values protect against chronic musculoskeletal complaints? The Nord-Trondelag Health Study (HUNT). Pain. vol. 113.
- (2005) Does hypertension protect against chronic musculoskeletal complaints? The Nord-Trøndelag Healt Study. Archives of Internal Medicine. vol. 165.
- (2005) Low socioeconomic status is associated with chronic musculoskeletal complaints among 46,901 adults in Norway. Scandinavian Journal of Public Health. vol. 33.
- (2005) A structured, nurse-led intervention program improves quality of life in patients with epilepsy: A ramdomized, controlled trial. Epilepsy & Behavior. vol. 7.
- (2005) ACE inhibitors and AT(1) receptor blockers. Cephalalgia. vol. 25.
- (2004) A Structured nurse intervention programme improves quality of life in patients with epilepsy. A randomised controlled study. Epilepsia. vol. 45.
- (2004) ACE inhibitors and AT1 receptor Blockers. 7th EHF congress, Program and abstract book.